Correspondence 0001493152-23-023420 from INVO Fertility, Inc. (IVF)
INVO Fertility, Inc.
Date: July 5, 2023 · CIK: 0001417926 · Accession: 0001493152-23-023420
AI Filing Summary & Sentiment
File numbers found in text: 333-272872
Letter
INVO BIOSCIENCE, INC.
BROADCAST COURT
Sarasota, florida 32240
July 5, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: INVO Bioscience, Inc.
Registration Statement on Form S-1
File No. 333-272872
Ladies and Gentlemen:
INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective date of the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on Friday July 7, 2023, or as soon thereafter as practicable.
Very truly yours,
INVO BIOSCIENCE, INC.
Show Raw Text
CORRESP
1
filename1.htm
INVO BIOSCIENCE, INC.
5582
BROADCAST COURT
Sarasota,
florida 32240
July 5, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
INVO Bioscience, Inc.
Registration Statement on Form S-1
File No. 333-272872
Ladies and Gentlemen:
INVO Bioscience,
Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the effective
date of the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on Friday July 7, 2023,
or as soon thereafter as practicable.
Very truly yours,
INVO BIOSCIENCE, INC.
By:
/s/
Steven Shum
Steven Shum
Chief Executive Officer